atazanavir sulfate has been researched along with Sensitivity and Specificity in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 12 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bertz, RJ; Burger, DM; Huisman, A; Koopmans, P; Neisingh, H; Rongen, GA; Van Ewijk, N; Van Uden, P | 1 |
Cattaneo, D; Maggiolo, F; Perico, N; Ripamonti, D | 1 |
Boesmans, D; Di Fazio, V; Elens, L; Haufroid, V; Vanbinst, R; Veriter, S; Wallemacq, P | 1 |
Burzawa, S; Couerbe, P; Jemal, M; Loizillon, E; Schuster, A; Whigan, D | 1 |
Gatz, M; Jemal, M; Rao, S; Whigan, D | 1 |
Beijnen, JH; Crommentuyn, KM; Hillebrand, MJ; Huitema, AD; Rosing, H | 1 |
Dailly, E; Jolliet, P; Raffi, F | 1 |
Cateau, E; Dupuis, A; Le Moal, G; Tournier, N; Venisse, N | 1 |
de Hoon, J; Van Wijngaerden, E; Verbesselt, R | 1 |
Azoulay, S; Burger, A; Créminon, C; Duval, D; Garraffo, R; Grassi, J; Lavrut, T; Nevers, MC; Roucairol, C | 1 |
Choi, SO; Kashuba, AD; Rezk, NL | 1 |
DiFrancesco, R; Donnelly, J; Fischl, MA; Gripshover, B; McCance-Katz, EF; Moody, DE; Morse, GD; Reichman, RC; Zingman, BS | 1 |
12 other study(ies) available for atazanavir sulfate and Sensitivity and Specificity
Article | Year |
---|---|
The effect of atazanavir and atazanavir/ritonavir on UDP-glucuronosyltransferase using lamotrigine as a phenotypic probe.
Topics: Administration, Oral; Adult; Anti-HIV Agents; Atazanavir Sulfate; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Glucuronosyltransferase; Humans; Lamotrigine; Male; Middle Aged; Molecular Probe Techniques; Oligopeptides; Phenotype; Prospective Studies; Pyridines; Reference Values; Ritonavir; Sensitivity and Specificity; Triazines; Young Adult | 2008 |
Determination of atazanavir in human plasma by high-performance liquid chromatography with UV detection.
Topics: Atazanavir Sulfate; Calibration; Chromatography, High Pressure Liquid; Female; HIV Protease Inhibitors; Humans; Oligopeptides; Pregnancy; Pyridines; Reference Standards; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2008 |
Quantification of 8 HIV-protease inhibitors and 2 nonnucleoside reverse transcriptase inhibitors by ultra-performance liquid chromatography with diode array detection.
Topics: Alkynes; Atazanavir Sulfate; Benzoxazines; Carbamates; Chromatography, High Pressure Liquid; Cyclopropanes; Furans; HIV Protease Inhibitors; Humans; Indinavir; Lopinavir; Nelfinavir; Nevirapine; Oligopeptides; Pyridines; Pyrimidinones; Pyrones; Reproducibility of Results; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Sensitivity and Specificity; Solid Phase Extraction; Sulfonamides | 2009 |
Quantitative determination of the HIV protease inhibitor atazanavir (BMS-232632) in human plasma by liquid chromatography-tandem mass spectrometry following automated solid-phase extraction.
Topics: Atazanavir Sulfate; Automation; Calibration; Chromatography, High Pressure Liquid; HIV Protease Inhibitors; Humans; Mass Spectrometry; Oligopeptides; Pyridines; Reference Standards; Sensitivity and Specificity | 2003 |
Liquid chromatography-tandem mass spectrometric quantitative determination of the HIV protease inhibitor atazanavir (BMS-232632) in human peripheral blood mononuclear cells (PBMC): practical approaches to PBMC preparation and PBMC assay design for high-th
Topics: Atazanavir Sulfate; Calibration; HIV Protease Inhibitors; Humans; Monocytes; Oligopeptides; Pyridines; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2003 |
Simultaneous quantification of the new HIV protease inhibitors atazanavir and tipranavir in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
Topics: Atazanavir Sulfate; Chromatography, High Pressure Liquid; HIV Infections; HIV Protease Inhibitors; Humans; Oligopeptides; Pyridines; Pyrones; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Sulfonamides | 2004 |
Determination of atazanavir and other antiretroviral drugs (indinavir, amprenavir, nelfinavir and its active metabolite M8, saquinavir, ritonavir, lopinavir, nevirapine and efavirenz) plasma levels by high performance liquid chromatography with UV detecti
Topics: Atazanavir Sulfate; Chromatography, High Pressure Liquid; HIV Protease Inhibitors; Humans; Oligopeptides; Pyridines; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2004 |
Determination of atazanavir in human plasma using solid-phase extraction and high-performance liquid chromatography.
Topics: Acetonitriles; Atazanavir Sulfate; Calibration; Carbon; Chromatography; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Monitoring; Drug Stability; HIV Protease Inhibitors; Humans; Oligopeptides; Pyridines; Quality Control; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Ultraviolet Rays | 2005 |
Simultaneous determination of 8 HIV protease inhibitors in human plasma by isocratic high-performance liquid chromatography with combined use of UV and fluorescence detection: amprenavir, indinavir, atazanavir, ritonavir, lopinavir, saquinavir, nelfinavir
Topics: Atazanavir Sulfate; Calibration; Carbamates; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Stability; Fluorescence; Furans; HIV Protease Inhibitors; Humans; Indinavir; Lopinavir; Nelfinavir; Oligopeptides; Pyridines; Pyrimidinones; Reproducibility of Results; Ritonavir; Saquinavir; Sensitivity and Specificity; Sulfonamides; Ultraviolet Rays | 2007 |
Quantitative immunoassay to measure plasma and intracellular atazanavir levels: analysis of drug accumulation in cultured T cells.
Topics: Animals; Antibodies; Atazanavir Sulfate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cattle; Cells, Cultured; Dipyridamole; Dose-Response Relationship, Drug; HIV Protease Inhibitors; Humans; Immunoassay; Oligopeptides; Phosphodiesterase Inhibitors; Pyridines; Rabbits; Sensitivity and Specificity; T-Lymphocytes | 2007 |
High-performance liquid chromatography assay for the determination of the HIV-protease inhibitor tipranavir in human plasma in combination with nine other antiretroviral medications.
Topics: Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Carbamates; Chromatography, High Pressure Liquid; Cyclopropanes; Drug Stability; Furans; HIV Protease Inhibitors; Humans; Indinavir; Lopinavir; Molecular Structure; Nelfinavir; Nevirapine; Oligopeptides; Oxazines; Pyridines; Pyrimidinones; Pyrones; Reproducibility of Results; Ritonavir; Saquinavir; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Sulfonamides; Time Factors | 2007 |
Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users.
Topics: Alkynes; Atazanavir Sulfate; Benzoxazines; Biological Assay; Buprenorphine; Calibration; Chromatography, Liquid; Cyclopropanes; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Mass Spectrometry; Molecular Structure; Narcotic Antagonists; Oligopeptides; Pyridines; Reproducibility of Results; Sensitivity and Specificity; Substance-Related Disorders; Tandem Mass Spectrometry | 2007 |